Patents/Assignees

Impact Therapeutics (Shanghai), Inc

5 patents in portfolio

US12544378utility2026
Solid Pharmaceutical Formulation of PARP Inhibitors and Use Thereof
0 cites
US12534454utility2026
Crystal Forms of 5-fluoro-1-(4-fluoro-3-(4-(pyrimidin-2-yl)piperazine-1-carbonyl)benzyl)quinazoline-2,4(1h,3h)-dione and Preparation Thereof
0 cites
US12492197utility2025
3,5-disubstituted Pyrazole Compounds as Kinase Inhibitors and Uses Thereof
0 cites
US12479848utility2025
Substituted Fused Heteroaromatic Bicyclic Compounds as Kinase Inhibitors and the Use Thereof
0 cites
US11547703utility2023
Substituted Fused Heteroaromatic Tricyclic Compounds as Kinase Inhibitors and the Use Thereof
0 cites